DNA
Companies
Nyse American
Ginkgo Bioworks Holdings Inc.
Health Care
$8.57
-$1.21 (-12.32%)
Price Chart
Overview
About DNA
the organism company ginkgo bioworks engineers new organisms to solve challenges across a range of industries from fuels to pharmaceutical production. our biological engineers make use of an in-house pipeline of synthetic biology technologies to design, build, and test new organisms.
Market Cap
$1.1B
Volume
8.6M
Avg. Volume
11.6M
P/E Ratio
-0.868256
Dividend Yield
0.00%
Employees
1.2K
Company Information
Latest News for DNA
Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
February 26, 2025
Ginkgo Bioworks CEO: Our AI model will learn to speak DNA just like ChatGPT learned English
September 1, 2023
Sensible Biotechnologies And Ginkgo Bioworks Announce Partnership To Make In Vivo RNA To Unlock The Promise Of RNA Therapeutics
April 3, 2023
Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q1 Loss, Tops Revenue Estimates
May 6, 2025
Risk & Correlation Analysis
Market Correlation
1.20
Moderate Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, DNA shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$1.1B
Volume8.6M
P/E Ratio-0.87
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 10, 2024Related Securities
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025